References and Notes
See, inter alia:
<A NAME="RS04608ST-1A">1a</A>
The
Art of Drug Synthesis
Johnson DS.
Li JJ.
Wiley-Interscience;
Hoboken:
2007.
<A NAME="RS04608ST-1B">1b</A>
Palladium
in Heterocyclic Chemistry: A Guide for the Synthetic Chemist
2nd
ed.:
Li JJ.
Gribble GW.
Elsevier;
Amsterdam:
2007.
<A NAME="RS04608ST-1C">1c</A>
Microwave-Assisted Synthesis
of Heterocycles
Van der Eycken E.
Kappe CO.
Springer;
New
York:
2006.
<A NAME="RS04608ST-2">2</A> See, for example:
Sheldon RA.
Arends I.
Hanefeld U.
Green Chemistry and
Catalysis
Wiley-VCH;
Weinheim:
2007.
<A NAME="RS04608ST-3">3</A> See:
Young DD.
Sripada L.
Deiters A.
J.
Comb. Chem.
2007,
9:
735 ;
and references therein
For recent reviews, see:
<A NAME="RS04608ST-4A">4a</A>
Agenet N.
Buisine O.
Slowinski F.
Gandon V.
Aubert C.
Malacria M. In Organic
Reactions
Vol. 68:
RajanBabu TV.
Wiley;
Hoboken:
2007.
p.1
<A NAME="RS04608ST-4B">4b</A>
Gandon V.
Aubert C.
Malacria M.
Chem.
Commun.
2006,
2209
<A NAME="RS04608ST-4C">4c</A>
Chopade PR.
Louie J.
Adv. Synth.
Catal.
2006,
348:
2307
<A NAME="RS04608ST-4D">4d</A>
Miljanić O.
Vollhardt KPC. In
Carbon-Rich Compounds:
From Molecules to Materials
Haley MM.
Tykwinski RR.
Wiley-VCH;
Weinheim:
2006.
p.140
<A NAME="RS04608ST-4E">4e</A>
Kotha S.
Brahmachar E.
Lahiri K.
Eur.
J. Org. Chem.
2005,
4741
<A NAME="RS04608ST-4F">4f</A>
Yamamoto Y.
Curr.
Org. Chem.
2005,
9:
1699
<A NAME="RS04608ST-4G">4g</A> For an early review of
CpCo-mediated [2+2+2] cycloadditions, see:
Vollhardt KPC.
Angew.
Chem., Int. Ed. Engl.
1984,
23:
539
Other complexes based on Ru, Rh,
and Ni, reported to effect the cocycloaddition of two alkyne units
to double bonds, failed for these substrates. For recent leading
references to such complexes, see:
<A NAME="RS04608ST-5A">5a</A>
Varela JA.
Rubín SG.
Castedo L.
Saá C.
J.
Org. Chem.
2008,
73:
1320
<A NAME="RS04608ST-5B">5b</A>
Shibata T.
Tsuchikama K.
Org. Biomol. Chem.
2008,
6:
1317
<A NAME="RS04608ST-5C">5c</A>
Rayabarapu DK.
Cheng C.-H.
Acc. Chem. Res.
2007,
40:
971
<A NAME="RS04608ST-5D">5d</A>
Tanaka K.
Nishida G.
Sagae H.
Hirano M.
Synlett
2007,
1426
Furans and thiophenes:
<A NAME="RS04608ST-6A">6a</A>
Boese R.
Harvey DF.
Malaska MJ.
Vollhardt KPC.
J.
Am. Chem. Soc.
1994,
116:
11153
<A NAME="RS04608ST-6B">6b</A>
Peréz D.
Siesel BA.
Malaska MJ.
David E.
Vollhardt KPC.
Synlett
2000,
306
Indoles:
<A NAME="RS04608ST-6C">6c</A>
Eichberg MJ.
Vollhardt KPC. In
Strategies and Tactics in Organic Synthesis
Vol.
4:
Harmata M.
Elsevier
Science;
Oxford:
2004.
Chap 14.
p.365
<A NAME="RS04608ST-6D">6d</A>
Eichberg MJ.
Dorta RL.
Grotjahn DB.
Lamottke K.
Schmidt M.
Vollhardt KPC.
J.
Am. Chem. Soc.
2001,
123:
9324
<A NAME="RS04608ST-6E">6e</A>
Eichberg MJ.
Dorta RL.
Lamottke K.
Vollhardt KPC.
Org.
Lett.
2000,
2:
2479
<A NAME="RS04608ST-6F">6f</A>
Boese R.
Van Sickle AP.
Vollhardt KPC.
Synthesis
1994,
1374
<A NAME="RS04608ST-6G">6g</A>
Grotjahn DB.
Vollhardt KPC.
J.
Am. Chem. Soc.
1986,
108:
2091
<A NAME="RS04608ST-6H">6h</A> Pyrroles:
Sheppard GS.
Vollhardt KPC.
J.
Org. Chem.
1986,
51:
5496
<A NAME="RS04608ST-6I">6i</A> Imidazoles:
Boese R.
Knölker H.-J.
Vollhardt KPC.
Angew. Chem., Int. Ed.
Engl.
1987,
26:
1035
Pyrimidines:
<A NAME="RS04608ST-6J">6j</A>
Pellissier H.
Rodriguez J.
Vollhardt KPC.
Chem. Eur. J.
1999,
5:
3549
<A NAME="RS04608ST-6K">6k</A>
Boese R.
Rodriguez J.
Vollhardt KPC.
Angew. Chem., Int. Ed. Engl.
1991,
30:
993
Pyridones:
<A NAME="RS04608ST-6L">6l</A>
Aubert C.
Betschmann P.
Eichberg MJ.
Gandon V.
Geny A.
Heckrodt TJ.
Lehmann J.
Malacria M.
Masjost B.
Paredes E.
Vollhardt KPC.
Whitener GD.
Chem. Eur. J.
2007,
13:
7443
<A NAME="RS04608ST-6M">6m</A>
Aubert C.
Gandon V.
Heckrodt TJ.
Malacria M.
Paredes E.
Vollhardt KPC.
Chem.
Eur. J.
2007,
13:
7466
<A NAME="RS04608ST-7A">7a</A>
Geny A.
Lebuf D.
Rouquié G.
Vollhardt KPC.
Malacria M.
Gandon V.
Aubert C.
Chem. Eur. J.
2007,
13:
5408
<A NAME="RS04608ST-7B">7b</A>
Gandon V.
Leboeu f D.
Amslinger S.
Vollhardt KPC.
Malacria M.
Aubert C.
Angew. Chem. Int.
Ed.
2005,
44:
7114
For a recent compilation of references
to cycloadditions with alkynyl boronates, see:
<A NAME="RS04608ST-8A">8a</A>
Delaney PM.
Browne DL.
Adams H.
Plant A.
Harrity JPA.
Tetrahedron
2008,
64:
866
For reviews on dienyl- and vinylboranes, see:
<A NAME="RS04608ST-8B">8b</A>
Albrecht K.
Kaufmann DE. In
Science of Synthesis
Vol.
6:
Kaufmann DE.
Matteson DS.
Thieme;
Stuttgart:
2005.
p.697
<A NAME="RS04608ST-8C">8c</A>
Vaultier M.
Alcaraz G. In Science
of Synthesis
Vol. 6:
Kaufmann DE.
Matteson DS.
Thieme;
Stuttgart:
2005.
p.721
<A NAME="RS04608ST-8D">8d</A> For a monograph, see:
Boronic Acids: Preparation and Applications
in Organic Synthesis and Medicine
Hall DG.
Wiley-VCH;
Weinheim:
2005.
<A NAME="RS04608ST-8E">8e</A> See also:
Gandon V.
Aubert C.
Malacria M.
Curr. Org. Chem.
2005,
9:
1699
<A NAME="RS04608ST-9">9</A> See also:
Gandon V.
Aubert C.
Malacria M.
Vollhardt KPC.
Chem.
Commun.
2008,
1599
See, for example:
<A NAME="RS04608ST-10A">10a</A>
Murakami M.
Usui I.
Hasegawa M.
Matsuda T.
J. Am. Chem. Soc.
2005,
127:
1366
<A NAME="RS04608ST-10B">10b</A>
Pereira S.
Srebnik M.
Organometallics
1995,
14:
3127
<A NAME="RS04608ST-11">11</A>
Gandon V.
Agenet N.
Vollhardt KPC.
Malacria M.
Aubert C.
J. Am. Chem. Soc.
2006,
128:
8509
<A NAME="RS04608ST-12">12</A>
Representative
Cyclization Conditions; Synthesis of 5: To a degassed solution
of N-(4-pentynoyl) indole (1;6g,¹4 197 mg, 1 mmol)
and 4,4,5,5-tetramethyl-2-(3-methylbut-1-ynyl)[1,3,2]dioxaborolane
(2; 242 mg, 1.25 mmol) in anhyd THF (15
mL) at 0 ˚C under an atmosphere of argon was added η5-cyclopentadienylbis(ethene)cobalt
(150 mg, 0.833 mmol) in anhyd, degassed THF (6 mL) over a period
of 3 h via syringe pump. The ensuing dark-red solution was treated with
bright yellow Fe(NO3)3˙9H2O
(337 mg, 0.834 mmol) in THF-H2O (5 mL, 3:1).
After stirring for 5 min at 0 ˚C, the brown mixture was
poured into iced water (50 mL) and the solution was extracted with
CH2Cl2 (3 × 100 mL), followed by
sat. aq NaHCO3 (3 × 150 mL). The extracts were
dried (MgSO4), filtered through a short silica gel column
to give a red-orange foam, and then subjected to flash chromatography
on silica gel (hexanes-acetone, 9:1) to yield 5 (189 mg, 58%) as a white solid;
mp 91-92 ˚C.
All new compounds gave satisfactory
elemental analytical and/or HRMS data. For selected spectra,
see: 3: ¹H NMR (500
MHz, CDCl3): δ = 1.21 (d, J = 7.0 Hz, 3 H, (CH
3)2CH], 1.25
(s, 6 H, Me), 1.32 (s, 6 H, Me), 1.48 [d, J = 6.5
Hz, 3 H, (CH
3)2CH],
1.80-1.85 (m, 1 H, CH2), 1.98-2.03
(m, 1 H, CH2), 2.52-2.66 [m, 3 H, CH2,
(CH3)2CH],
2.55 (d, J = 8.0 Hz, 1 H, CH),
3.24 (d, J = 7.5 Hz, 1 H, CH),
4.52 (s, 5 H, Cp), 5.01 (s, 1 H, CH), 6.98 (t, J = 7.5
Hz, 1 H, CHarom), 7.23 (t, J = 7.5
Hz, 1 H, CHarom), 7.77 (d, J = 7.5
Hz, 1 H, CHarom), 8.20 (d, J = 7.5
Hz, 1 H, CHarom). ¹³C NMR
(126 MHz, CDCl3): δ = 20.5, 24.5, 26.0,
26.1, 30.4, 31.5, 32.5, 45.2, 63.4, 64.9, 72.1, 81.1, 83.4, 106.4,
116.1, 122.8, 126.4, 127.6, 135.2, 142.7, 169.8; C-B not
detected. MS (FAB, NBA): m/z (%) = 515 (100) [M+].
4: ¹H NMR (500 MHz,
CDCl3): δ = 0.62 [d, J = 6.5 Hz, 3 H, (CH
3)2CH],
1.29 [d, J = 7.0 Hz,
3 H, (CH
3)2CH],
1.33 (s, 6 H, Me), 1.35 (s, 6 H, Me), 1.75-1.81 (m, 1 H,
CH2), 2.28 (m, 1 H, CH2), 2.43-2.48
(m, 1 H, CH2), 2.69-2.76 (m, 1 H, CH2),
3.08 [sep, J = 6.5
Hz, 1 H, (CH3)2CH],
3.83 (d, J = 11.0 Hz, 1 H, CH),
4.41 (d, J = 11.5 Hz, 1 H, CH),
4.67 (s, 1 H, CH), 4.68 (s, 5 H, Cp), 6.83 (t, J = 7.0
Hz, 1 H, CHarom), 6.99-7.04 (m, 2 H, CHarom),
7.68 (d, J = 7.5 Hz, 1 H, CHarom). ¹³C
NMR (126 MHz, CDCl3): δ = 19.5, 24.8,
25.5, 25.8, 29.5, 31.3, 33.3, 44.4, 62.1, 67.1, 76.3, 81.1, 82.8,
109.7, 115.5, 123.2, 124.4, 127.0, 133.6, 140.8, 169.8; C-B
not detected. MS (FAB, NBA): m/z (%) = 515 (100) [M+].
5: ¹H NMR (400 MHz,
CDCl3): δ = 0.93 [d, J = 6.8 Hz, 3 H, (CH
3)2CH],
0.96 [d, J = 6.8 Hz,
3 H, (CH
3)2CH],
1.32 (s, 6 H, Me), 1.35 (s, 6 H, Me), 2.47-2.57 (m, 2 H,
CH2), 2.65-2.81 (m, 2 H, CH2), 3.46 [sep, J = 6.9 Hz, 1 H, (CH3)2CH], 4.57 (d, J = 12.8
Hz, 1 H, CH), 5.01 (dd, J = 1.2,
13.6 Hz, 1 H, CH), 5.88 (br s, 1 H, CH), 6.98 (t, J = 7.2
Hz, 1 H, CHarom), 7.16 (t, J = 7.8
Hz, 1 H, CHarom), 7.31 (d, J = 7.6
Hz, 1 H, CHarom), 8.12 (d, J = 7.6
Hz, 1 H, CHarom). ¹³C NMR (101
MHz, CDCl3): δ = 21.0, 21.5, 24.8,
25.1, 26.0, 30.9, 32.8, 41.2, 58.6, 83.3, 115.9, 118.4, 123.6, 124.4,
127.5, 133.8, 136.0, 140.1, 152.1, 170.2; C-B not detected.
MS (70 eV, EI): m/z (%) = 391 (100) [M+],
286 (35), 260 (30). IR (neat): 2977, 1673, 1594, 1480, 1461, 1390,
1317, 1289, 1269, 1143, 1017, 857, 752, 732, 672 cm-¹.
7: ¹H NMR (500 MHz,
CDCl3): δ = 0.85 (t, J = 6.8
Hz, 3 H, Me), 1.25 (m, 8 H, CH2), 1.32 (s, 6 H, Me),
1.35 (s, 6 H, Me), 2.19-2.23 (m, 1 H, CH2),
2.47-2.58 (m, 3 H, CH2), 2.66-2.79
(m, 2 H, CH2), 4.57 (d, J = 14.0
Hz, 1 H, CH), 5.01 (d, J = 13.5
Hz, 1 H, CH), 5.70 (s, 1 H, CH), 6.97 (t, J = 7.0
Hz, 1 H, CHarom), 7.15 (t, J = 7.8
Hz, 1 H, CHarom), 7.33 (d, J = 7.5
Hz, 1 H, CHarom), 8.12 (d, J = 8.0
Hz, 1 H, CHarom). ¹³C NMR
(126 MHz, CDCl3): δ = 14.1, 22.6, 25.0,
25.7 (2 × C), 29.1, 29.8, 31.7, 32.7, 35.4, 41.2, 58.6,
83.3, 115.9, 123.6, 123.7, 124.5, 127.5, 133.5, 136.0, 140.1, 148.2,
170.3; C-B not detected. MS (70 eV, EI): m/z (%) = 433 (20) [M+],
432 (40), 431 (100), 361 (45), 285 (95). IR (neat): 2976, 2926, 2855,
1673, 1594, 1479, 1459, 1396, 1379, 1328, 1317, 1268, 1143, 1020,
857, 752 cm-¹.
9:
Diastereomer 1: ¹H NMR (500 MHz, CDCl3): δ = 1.32
(s, 6 H, Me), 1.36 (s, 6 H, Me), 1.50 (m, 2 H, CH2),
1.57 (m, 2 H, CH2), 1.68 (m, 1 H, CH2), 1.80
(m, 1 H, CH2), 2.52-2.58 (m, 2 H, CH2),
2.67-2.80 (m, 2 H, CH2), 3.44-3.50
(m, 1 H, CH2), 3.83-3.89 (m, 1 H, CH2),
4.20 (d, J = 11.5 Hz, 1 H, CH2),
4.58-4.67 (m, 3 H, CH, CHO, CH2), 5.04 (br d, J = 13.5 Hz, 1 H, CH), 6.00
(s, 1 H, CH), 6.97 (t, J = 7.5
Hz, 1 H, CHarom), 7.17 (t, J = 7.8
Hz, 1 H, CHarom), 7.34 (d, J = 7.5 Hz,
1 H, CHarom), 8.14 (d, J = 8.0
Hz, 1 H, CHarom). ¹³C NMR (126
MHz, CDCl3): δ = 19.5, 25.0 (2 × C),
25.4, 25.9, 30.7, 32.7, 41.3, 58.5, 62.2, 67.5, 83.8, 97.7, 110.1
(br, C-B), 116.1, 120.9, 123.6, 24.4, 127.7, 133.7, 135.1,
140.1, 143.0, 170.1. MS (70 eV, EI): m/z (%) = 463 (16) [M+],
462 (6), 461 (10), 363 (32), 361 (52). IR (neat): 3053, 2977, 2941,
2870, 1671, 1595, 1480, 1460, 1391, 1381, 1321, 1269, 1202, 1142,
1076, 1022, 869, 754, 736 cm-¹. Diastereomer
2: ¹H NMR (500 MHz, CDCl3): δ = 1.32
(s, 6 H, Me), 1.36 (s, 6 H, Me), 1.48-1.59 (m, 4 H, CH2),
1.66-1.83 (m, 2 H, CH2), 2.52-2.58
(m, 2 H, CH2), 2.67-2.80 (m, 2 H, CH2),
3.44-3.50 (m, 1 H, CH2), 3.83-3.89
(m, 1 H, CH2), 4.17 (d, J = 12.0
Hz, 1 H, CH2), 4.58-4.67 (m, 3 H, CH, CHO, CH2), 5.03
(d, J = 13.5 Hz, 1 H, CH), 6.00
(s, 1 H, CH), 6.97 (t,
J = 7.5
Hz, 1 H, CHarom), 7.17 (t, J = 7.8
Hz, 1 H, CHarom), 7.36 (d, J = 8.0
Hz, 1 H, CHarom), 8.14 (d, J = 8.0
Hz, 1 H, CHarom). ¹³C NMR
(126 MHz, CDCl3): δ = 19.4, 24.9, 25.0, 25.4,
25.9, 30.5, 32.7, 41.3, 58.5, 62.1, 68.0, 83.8, 98.6, 110.2 (br,
C-B), 116.1, 120.9, 123.6, 124.5, 127.7, 133.7, 135.2,
140.1, 143.3, 170.1.
11/12 mixture, major regioisomer 11: ¹H NMR (400 MHz, CDCl3): δ = 0.18
(s, 9 H, SiMe3), 1.33 (s, 6 H, Me), 1.37 (s, 6 H, Me),
2.45-3.03 (m, 4 H, CH2), 4.60 (d, J = 14.0 Hz, 1 H, CH), 5.01
(br d, J = 14.0 Hz, 1 H, CH),
6.01 (br s, 1 H, CH), 6.98 (t, J = 7.4
Hz, 1 H, CHarom), 7.17 (t, J = 7.8
Hz, 1 H, CHarom), 7.38 (d, J = 7.6
Hz, 1 H, CHarom), 8.14 (d, J = 7.6 Hz,
1 H, CHarom). ¹³C NMR (101
MHz, CDCl3): δ = 0.75, 24.6, 25.6,
26.1, 32.8, 42.1, 58.4, 83.9, 116.0, 122.7, 123.6, 124.6, 127.5,
130.8, 135.7, 140.2, 147.6, 170.5; C-B not detected. Minor
regioisomer 12: ¹H
NMR (400 MHz, CDCl3): δ = 0.36 (s,
9 H, SiMe3), 1.25 (s, 6 H, Me), 1.26 (s, 6 H, Me), 2.45-3.03
(m, 4 H, CH2), 4.52 (d, J = 12.8
Hz, 1 H, CH), 5.01 (dd, J = 1.6,
14.0 Hz, 1 H, CH), 6.11 (s, 1 H, CH), 6.98 (dt, J = 1.2,
7.4 Hz, 1 H, CHarom), 7.17 (t, J = 7.8 Hz,
1 H, CHarom), 7.38 (d, J = 7.6
Hz, 1 H, CHarom), 8.14 (d, J = 7.6
Hz, 1 H, CHarom). ¹³C NMR
(101 MHz, CDCl3): δ = 1.38, 24.8, 25.0,
25.1, 32.7, 43.3, 59.5, 83.8, 115.7, 122.5, 123.5, 124.3, 127.8,
129.1, 134.9, 140.2, 147.6, 170.5; C-B not detected. MS
(70 eV, EI): m/z (%) = 421
(52) [M+], 420 (66), 404 (28),
348 (22), 347 (20), 322 (30), 278 (65), 83 (100). IR (neat): 2979,
1667, 1594, 1537, 1481, 1460, 1398, 1317, 1247, 1216, 1142, 1091,
1058, 1020, 983, 960, 844, 755, 701, 667 cm-¹.
14/15 mixture,
major regioisomer 14: ¹H
NMR (500 MHz, CDCl3): δ = 1.07 (s,
6 H, Me), 1.13 (s, 6 H, Me), 2.60 (m, 2 H, CH2), 2.79
(m, 2 H, CH2), 4.70 (d, J = 13.5
Hz, 1 H, CH), 5.11 (d, J = 13.5
Hz, 1 H, CH), 6.07 (br s, 1 H, CH), 7.05 (t, J = 7.5
Hz, 1 H, CHarom), 7.20-7.40 (m, 6 H, CHarom),
7.52 (d, J = 7.5 Hz, 1 H, CHarom),
8.21 (d, J = 8.0 Hz, 1 H, CHarom). Minor
regioisomer 15: ¹H
NMR (500 MHz, CDCl3): δ = 1.16 (s,
6 H, Me), 1.20 (s, 6 H, Me), 2.60 (m, 2 H, CH2), 2.79
(m, 2 H, CH2), 4.81 (d, J = 14.0
Hz, 1 H, CH), 5.17 (d, J = 14.0 Hz,
1 H, CH), 5.95 (br s, 1 H, CH), 6.67 (t, J = 7.5
Hz, 1 H, CHarom), 7.12 (t, J = 7.5
Hz, 1 H, CHarom), 7.20-7.40 (m, 6 H, CHarom),
8.17 (d, J = 8.0 Hz, 1 H, CHarom). ¹³C
NMR (126 MHz, CDCl3; 14/15 mixture): δ = 24.2,
24.6 (2 × C), 24.7, 26.0, 26.1, 30.9, 32.8, 33.1, 36.6,
41.9, 44.0, 58.1, 58.9, 83.5, 83.6, 116.0, 116.2, 120.8, 123.0,
123.1, 123.8, 124.7, 125.0, 127.1, 127.2, 127.7, 127.8, 127.9 (2 × C),
129.0, 132.2, 132.4, 134.9, 140.2, 140.3, 141.4, 142.8, 144.7, 144.9, 169.4,
169.9; C-B (2 × C) not detected. MS (70 eV, EI):
m/z (%) = 425
(18) [M+], 424 (33), 423 (86),
307 (52), 297 (60), 169 (41), 84 (100). IR (neat): 3015, 2979, 2930,
1705, 1655, 1594, 1482, 1408, 1367, 1317, 1141, 1066, 1023, 853, 755,
702, 667 cm-¹.
17: ¹H
NMR (500 MHz, CDCl3): δ = 0.88 [d, J = 7.0 Hz, 3 H, (CH
3)2CH],
0.91 [d, J = 7.0 Hz,
3 H, (CH
3)2CH],
1.15 (s, 6 H, Me), 1.20 (s, 6 H, Me), 2.47 (m, 2 H, CH2),
2.57 (dd,
J = 6.4,
14.3 Hz, 1 H, CH2), 2.66 (dd, J = 6.4,
13.0 Hz, 1 H, CH2), 3.34 [sep, J = 7.0
Hz, 1 H, (CH3)2CH],
4.18 (br d, J = 14.6 Hz, 1 H,
CH), 4.70 (d, J = 14.4 Hz, 1
H, CH), 5.36 (m, 1 H, CH), 5.83 (br s, 1 H, CH), 6.80 (m, 1 H, CH). ¹³C
NMR (126 MHz, CDCl3): δ = 21.2, 24.4,
24.7, 24.9, 26.6, 30.9, 31.6, 45.4, 55.5, 82.9, 117.4, 117.9, 125.0,
132.5, 150.8, 167.1; C-B not detected. MS (70 eV, EI): m/z (%) = 341
(12) [M+], 340 (11), 339 (30),
326 (11), 298 (10), 224 (6), 198 (8), 185 (9), 129 (16), 83 (100).
IR (neat): 2976, 2872, 1716, 1643, 1518, 1468, 1412, 1371, 1220,
1144, 1110, 1078, 1016, 983, 951, 924, 885, 858, 831, 787, 744,
674 cm-¹.
19: ¹H
NMR (500 MHz, CDCl3): δ = 1.04 [d, J = 6.9 Hz, 6 H, (CH
3)2CH],
1.21 (s, 12 H, Me), 1.95 (quint, J = 6.0
Hz, 2 H, CH2), 2.50 (sep, J = 7.0
Hz, 1 H, CH), 2.54 (td, J = 2.0, 6.0
Hz, 2 H, CH2), 3.95 (t, J = 6.0
Hz, 2 H, CH2), 5.38 (s, 1 H, CH), 6.16 (m, 1 H, CH),
6.42 (m, 1 H, CH), 6.59 (m, 1 H, H-2), 6.61 (br s, 1 H, CH). ¹³C
NMR (126 MHz, CDCl3): δ = 21.7, 23.9,
24.9, 25.6, 37.2, 45.5, 82.7, 103.1, 108.3, 119.9, 120.7, 129.6,
131.8, 165.0; C-B not detected. MS (70 eV, EI): m/z (%) = 327
(10) [M+], 312 (10), 284 (26),
184 (40), 59 (100). IR (neat): 3100, 2972, 2871, 1695, 1620, 1458, 1380,
1331, 1259, 1107, 1077, 970, 851, 756, 722, 667 cm-¹.
<A NAME="RS04608ST-13A">13a</A>
Grotjahn DB.
Vollhardt KPC.
J. Am. Chem. Soc.
1990,
112:
5653
<A NAME="RS04608ST-13B">13b</A>
Grotjahn DB.
Vollhardt KPC.
Synthesis
1993,
579
<A NAME="RS04608ST-13C">13c</A>
Aechtner, T.; Barry,
D. A.; Grotjahn, D. B.; Vollhardt, K. P. C. unpublished results.
<A NAME="RS04608ST-14">14</A> The acylation of indole was modified
from that described in ref. 6b, according to:
Teranishi K.
Nakatsuka S.
Goto T.
Synthesis
1994,
1018